Exagen inc. to participate in the william blair 42nd annual growth stock conference

San diego, may 26, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the william blair 42nd annual growth stock conference, which takes place june 6-9, 2022, in chicago at the loews chicago hotel. ron rocca, exagen's president and chief executive officer, and kamal adawi, exagen's chief financial officer, will present on thursday, june 9th, at 12:40 pm ct. interested parties may access the webcast of the presentation using a link on exagen's website at https://investors.exagen.com/events.
XGN Ratings Summary
XGN Quant Ranking